Brief: Orchid Pharma’s ‘Exblifep’ Receives USFDA Approval
Feb 23 (Reuters) - Orchid Pharma Ltd ORCD.NS :
* ORCHID PHARMA’S ‘EXBLIFEP’ RECEIVES USFDA APPROVAL
* PRODUCT IS EXPECTED TO BE LAUNCHED WITHIN NEXT COUPLE OF
QTRS IN
US MARKET
Source text for Eikon: ID:nNSE38cM3C
Further company coverage: ORCD.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Orchid Pharma
See all newsBrief: Orchid Pharma Approves Enabling Resolution To Explore Fund Raising Via Equity Or Other Securities
Brief: Orchid Pharma To Consider And Evaluate Various Options For Raising Funds
Brief: Orchid Pharma June-Quarter Consol Profit 25.8 Million Rupees
India's Orchid Pharma jumps on pact to commercialize Exblifep in Russia
Refile: INDIA STOCKS-Indian shares set to open lower as US-Iran tensions lift oil prices